Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia [Phase 2]
Phase 2 trial assessing safety and efficacy of pegylated interferon-alpha-2b added to dasatinib in newly diagnosed chronic phase myeloid leu…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies [Phase 1, Phase 2]
A completed Phase 1/2 study of PRI-724 in adults with advanced myeloid malignancies (acute and chronic myeloid leukemia) evaluated safety an…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia [Phase 2]
Phase 2 trial update evaluating an induction-maintenance treatment protocol for Philadelphia chromosome-positive chronic myeloid leukemia, r…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
This Mexican multicenter descriptive study reports the frequency and severity of pleural effusions in chronic myeloid leukemia patients trea…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies [Phase 1]
Hoffmann-La Roche announced completion of an extension study for RO5045337 in participants from previous Roche cancer studies, involving chr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients [Phase 2]
Phase II trial evaluating the tolerability and efficacy of bosutinib in patients with chronic myeloid leukemia in the chronic phase.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluated imatinib (Gleevec) for chronic myelomonocytic leukemia, chronic myeloid leukemia, and atypical chronic my…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia [NA]
Interventional study aiming to improve adherence to tyrosine kinase inhibitors in patients with chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [NA]
Clinical trial update reports results of a conditioning regimen using fludarabine and total-body irradiation followed by donor stem cell tra…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
Phase 2 trial evaluating haploidentical donor bone marrow transplantation in patients with high-risk hematologic cancers; results completed …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the use of nilotinib and imatinib after donor stem cell transplant in patients with acute ly…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluated haploidentical allogeneic transplantation with post-transplant regulatory T-cell infusion in…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [NA]
A terminated clinical trial evaluated mobilizing donor peripheral blood stem cells with plerixafor and filgrastim before donor transplant in…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update describing safety assessments for two infusion schedules of SNS-595 in patients with hematologic malignancies.…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced mye…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy [Phase 4]
Phase 4 trial assessing the efficacy and safety of nilotinib in chronic myeloid leukemia patients with suboptimal response to imatinib was t…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy [Phase 2, Phase 3]
This update reports the efficacy and safety outcomes of oral nilotinib (AMN107) in adults with chronic myeloid leukemia resistant or intoler…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Tasigna in Glivec-resistant or Intolerant Patients in CML [Phase 4]
Phase 4 trial results of nilotinib (Tasigna) in chronic myeloid leukemia patients who are resistant or intolerant to imatinib (Glivec). The …
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase [Phase 3]
Phase 3 trial evaluating nilotinib in adults with imatinib-resistant or intolerant chronic myeloid leukemia across blast crisis, accelerated…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase [Phase 4]
Phase 4 trial update on nilotinib as initial therapy for adults with Philadelphia chromosome/BCR-ABL-positive chronic myeloid leukemia in ch…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase [Phase 4]
Phase 4 study evaluating nilotinib in adults with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis, accelerated ph…